Of the 17 common human variants associated with the increased IPF risk, MUC5B is distinct in its aberrant upregulation specifically in alveoli, where patients with a MUC5B minor allele have a better prognosis following COVID-dependent acute lung injury (72, 73) and protection from childhood bacterial infections (74). The gene discussed is MUC5B; the disease is bacterial infectious disease.